OraSure Technologies | OSUR - Cost Of Sales

Stock Price
3.22
Daily Change
0.06 1.74%
Monthly
4.38%
Yearly
12.02%
Q2 Forecast
3.09

OraSure Technologies reported $15.43M in Cost of Sales for its fiscal quarter ending in December of 2025.





Cost Of Sales Change Date
Agilent USD 852M 19M Dec/2025
AngioDynamics USD 37.29M 786K Sep/2025
Becton, Dickinson and Co. USD 2.84B 2.35B Dec/2025
Bio Techne USD 104.6M 6.16M Dec/2025
Bio-Rad Laboratories USD 309.6M 3.3M Sep/2025
Bruker USD 528M 46.9M Dec/2025
Cerus USD 23.42M 3.61M Dec/2024
Charles River Laboratories USD 722.27M 28.81M Dec/2025
Danaher USD 2.87B 342M Dec/2025
Dentsply International USD 518M 55M Dec/2025
Dexcom USD 466.9M 11M Dec/2025
Illumina USD 400M 49M Dec/2025
Integra LifeSciences USD 193.44M 1.62M Dec/2025
Intuitive Surgical USD 961.9M 119.2M Dec/2025
IQVIA Holdings USD 3.24B 518M Dec/2025
Mesa Laboratories USD 21.92M 1.78M Sep/2024
Mettler Toledo International USD 473.97M 33.71M Dec/2025
Myriad Genetics USD 63M 1.1M Dec/2025
OraSure Technologies USD 15.43M 113K Dec/2025
Quidel USD 448.8M 1.21B Dec/2025
Repligen USD 94.08M 5.79M Dec/2025
Revvity USD 350.4M 26.05M Dec/2025
STAAR Surgical USD 14.06M 2.8M Dec/2025
Thermo Fisher Scientific USD 7.58B 674M Dec/2025
Trinity Biotech USD 7.84M 3.14M Sep/2025
Waters USD 374.94M 47.13M Dec/2025